Categories
trends

J&J shares vaccine results

Top 10 Results

1.J&J shares vaccine results

J&J shares vaccine results Johnson & Johnson said its single-shot coronavirus vaccine was 66% effective at preventing moderate to severe disease in a large clinical trial, although the figure …

2.J&J shares vaccine results

Johnson & Johnson chief scientific officer Dr. Paul Stoffels joins “Squawk on the Street” to discuss the results of its Covid vaccine trials. … Share Share Article via … J&J says its one-shot …

3.J&J shares vaccine results

Shares of Johnson & Johnson JNJ, 0.84% were up 0.9% in trading on Monday, as the company nears the anticipated disclosure of interim results from a late-stage clinical trial evaluating its…

4.J&J shares vaccine results

J&J said in mid-December it expects to share findings from the Phase 3 trial by the end of January, which would it the third company testing coronavirus vaccines in the U.S. to announce results …

5.J&J shares vaccine results

Johnson & Johnson JNJ -1.53% said it expects to report pivotal results of a large clinical trial of its Covid-19 vaccine by early next week, and to deliver 100 million doses for use in the U.S. by …

6.J&J shares vaccine results

Johnson & Johnson expects to report results from the eagerly-anticipated clinical trial of its COVID-19 vaccine next week, the US pharmaceutical’s chief financial officer told CNBC Tuesday.

7.J&J shares vaccine results

Results from the preliminary Phase 1 and 2 study of the Johnson & Johnson vaccine were published last week. They showed that the vaccine was safe and that 90% of its recipients produced antibodies…

8.J&J shares vaccine results

Results are from a Phase 1/2 study J&J is conducting in the U.S. and Belgium, which tested several different vaccine doses and regimens against placebo in about 800 healthy adults. Researchers are still collecting data, and participants haven’t yet received their second vaccination, which occurs 57 days after their first.

9.J&J shares vaccine results

The U.S. needs J.&J.’s one-shot vaccine more than ever. But the company is behind on manufacturing promises made in its Operation Warp Speed contract. By Carl Zimmer, Sharon LaFraniere and Noah …

10.J&J shares vaccine results

J&J reports positive phase 1/2 Covid vaccine trial results Johnson & Johnson ’s one-dose coronavirus vaccine is safe and appears to generate a promising immune response in both young and elderly…

News results

1.Wall St. drops after J&J vaccine data, GameStop effect weighs

U.S. stock indexes dropped, closing out the Friday session with the biggest weekly fall since October, as investors gauged the ramifications of Johnson & Johnson’s COVID-19 vaccine trial results, while a standoff between Wall Street hedge funds and small,

Published Date: 2021-01-30T03:06:00.0000000Z

2.J&J shares vaccine results

Johnson & Johnson said its single-shot coronavirus vaccine was 66% effective at preventing moderate to severe disease in a large clinical trial, although the figure varied across geographies.

Published Date: 2021-01-30T03:36:00.0000000Z

1  J&J Covid-19 Vaccine Is 66% Effective in Global Clinical Trial
Johnson & Johnson’s one-shot vaccine generated strong protection against Covid-19 in a large, late-stage trial, raising hopes that it can rapidly reshape a stumbling immunization campaign. In a study of more than 44,000 people, the vaccine prevented 66% of moderate to severe cases of Covid-19, according to a company statement Friday. And it …
Watch Video: https://www.youtube.com/watch?v=4sIGCCdjFec

1.Moderna COVID-19 vaccine

Moderna COVID-19 Vaccine, codenamed mRNA-1273, is a COVID-19 vaccine developed by the United States National Institute of Allergy and Infectious Diseases…

2.Pfizer–BioNTech COVID-19 vaccine

The Pfizer–BioNTech COVID‑19 vaccine, sold under the brand name Comirnaty, is a COVID-19 vaccine developed by BioNTech in cooperation with Pfizer. It…

3.Pfizer

celecoxib), an anti-inflammatory drug; and Prevnar 13, a pneumococcal conjugate vaccine. In 2016, Pfizer Inc. was expected to merge with Allergan to create the…

Leave a Reply